Reproductive health care across the lifecourse of the female cancer patient

Lisa A. Rubinsak, Mindy Sue Christianson, Aletha Akers, Jeanne Carter, Andrew M. Kaunitz, Sarah M. Temkin

Research output: Contribution to journalArticle

Abstract

Reproductive health is a key component of cancer care and survivorship, encompassing gynecologic issues ranging from contraception and fertility to treatment of sexual dysfunction and menopause. Yet, oncology providers are often unfamiliar with the management of gynecologic issues. In order to address the unmet needs of female cancer patients, reproductive health should be addressed at the time of cancer diagnosis and continue through survivorship. Universal screening for pregnancy intention can guide counseling on contraception and fertility preservation. Safe and efficacious contraceptive options for both patients undergoing active treatment and cancer survivors are available and can often offer non-contraceptive benefits such as regulation of menses. Prompt referral to reproductive endocrinology specialists allows patients to explore options for fertility preservation prior to the receipt of cancer-directed therapies. Due to a rapid drop in hormone levels, treatment-induced menopause often results in severe symptoms. In patients with induced menopause, balancing the risks of hormone therapy compared to the decreased quality of life and health concerns associated with early menopause may help patients with difficult decisions regarding symptom control. Cancer treatment impacts sexual function with both physical changes to the vulvovaginal tissues and altered relationship dynamics. Open discussions on the impact to sexual health are paramount to quality of life after cancer. While more data is needed in many areas, proactive management of reproductive health issues is crucial to quality of life in cancer survivorship. In this article, we review contemporary management of the reproductive health of the female cancer patient.

Original languageEnglish (US)
JournalSupportive Care in Cancer
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Reproductive Health
Delivery of Health Care
Menopause
Neoplasms
Fertility Preservation
Survival Rate
Quality of Life
Contraception
Therapeutics
Hormones
Menstruation
Endocrinology
Contraceptive Agents
Fertility
Survivors
Counseling
Referral and Consultation
Pregnancy
Health

Keywords

  • Cancer survivorship
  • Reproductive health

ASJC Scopus subject areas

  • Oncology

Cite this

Reproductive health care across the lifecourse of the female cancer patient. / Rubinsak, Lisa A.; Christianson, Mindy Sue; Akers, Aletha; Carter, Jeanne; Kaunitz, Andrew M.; Temkin, Sarah M.

In: Supportive Care in Cancer, 01.01.2018.

Research output: Contribution to journalArticle

Rubinsak, Lisa A. ; Christianson, Mindy Sue ; Akers, Aletha ; Carter, Jeanne ; Kaunitz, Andrew M. ; Temkin, Sarah M. / Reproductive health care across the lifecourse of the female cancer patient. In: Supportive Care in Cancer. 2018.
@article{2e08725af16341d58947681dc0822bb2,
title = "Reproductive health care across the lifecourse of the female cancer patient",
abstract = "Reproductive health is a key component of cancer care and survivorship, encompassing gynecologic issues ranging from contraception and fertility to treatment of sexual dysfunction and menopause. Yet, oncology providers are often unfamiliar with the management of gynecologic issues. In order to address the unmet needs of female cancer patients, reproductive health should be addressed at the time of cancer diagnosis and continue through survivorship. Universal screening for pregnancy intention can guide counseling on contraception and fertility preservation. Safe and efficacious contraceptive options for both patients undergoing active treatment and cancer survivors are available and can often offer non-contraceptive benefits such as regulation of menses. Prompt referral to reproductive endocrinology specialists allows patients to explore options for fertility preservation prior to the receipt of cancer-directed therapies. Due to a rapid drop in hormone levels, treatment-induced menopause often results in severe symptoms. In patients with induced menopause, balancing the risks of hormone therapy compared to the decreased quality of life and health concerns associated with early menopause may help patients with difficult decisions regarding symptom control. Cancer treatment impacts sexual function with both physical changes to the vulvovaginal tissues and altered relationship dynamics. Open discussions on the impact to sexual health are paramount to quality of life after cancer. While more data is needed in many areas, proactive management of reproductive health issues is crucial to quality of life in cancer survivorship. In this article, we review contemporary management of the reproductive health of the female cancer patient.",
keywords = "Cancer survivorship, Reproductive health",
author = "Rubinsak, {Lisa A.} and Christianson, {Mindy Sue} and Aletha Akers and Jeanne Carter and Kaunitz, {Andrew M.} and Temkin, {Sarah M.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1007/s00520-018-4360-5",
language = "English (US)",
journal = "Supportive Care in Cancer",
issn = "0941-4355",
publisher = "Springer Verlag",

}

TY - JOUR

T1 - Reproductive health care across the lifecourse of the female cancer patient

AU - Rubinsak, Lisa A.

AU - Christianson, Mindy Sue

AU - Akers, Aletha

AU - Carter, Jeanne

AU - Kaunitz, Andrew M.

AU - Temkin, Sarah M.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Reproductive health is a key component of cancer care and survivorship, encompassing gynecologic issues ranging from contraception and fertility to treatment of sexual dysfunction and menopause. Yet, oncology providers are often unfamiliar with the management of gynecologic issues. In order to address the unmet needs of female cancer patients, reproductive health should be addressed at the time of cancer diagnosis and continue through survivorship. Universal screening for pregnancy intention can guide counseling on contraception and fertility preservation. Safe and efficacious contraceptive options for both patients undergoing active treatment and cancer survivors are available and can often offer non-contraceptive benefits such as regulation of menses. Prompt referral to reproductive endocrinology specialists allows patients to explore options for fertility preservation prior to the receipt of cancer-directed therapies. Due to a rapid drop in hormone levels, treatment-induced menopause often results in severe symptoms. In patients with induced menopause, balancing the risks of hormone therapy compared to the decreased quality of life and health concerns associated with early menopause may help patients with difficult decisions regarding symptom control. Cancer treatment impacts sexual function with both physical changes to the vulvovaginal tissues and altered relationship dynamics. Open discussions on the impact to sexual health are paramount to quality of life after cancer. While more data is needed in many areas, proactive management of reproductive health issues is crucial to quality of life in cancer survivorship. In this article, we review contemporary management of the reproductive health of the female cancer patient.

AB - Reproductive health is a key component of cancer care and survivorship, encompassing gynecologic issues ranging from contraception and fertility to treatment of sexual dysfunction and menopause. Yet, oncology providers are often unfamiliar with the management of gynecologic issues. In order to address the unmet needs of female cancer patients, reproductive health should be addressed at the time of cancer diagnosis and continue through survivorship. Universal screening for pregnancy intention can guide counseling on contraception and fertility preservation. Safe and efficacious contraceptive options for both patients undergoing active treatment and cancer survivors are available and can often offer non-contraceptive benefits such as regulation of menses. Prompt referral to reproductive endocrinology specialists allows patients to explore options for fertility preservation prior to the receipt of cancer-directed therapies. Due to a rapid drop in hormone levels, treatment-induced menopause often results in severe symptoms. In patients with induced menopause, balancing the risks of hormone therapy compared to the decreased quality of life and health concerns associated with early menopause may help patients with difficult decisions regarding symptom control. Cancer treatment impacts sexual function with both physical changes to the vulvovaginal tissues and altered relationship dynamics. Open discussions on the impact to sexual health are paramount to quality of life after cancer. While more data is needed in many areas, proactive management of reproductive health issues is crucial to quality of life in cancer survivorship. In this article, we review contemporary management of the reproductive health of the female cancer patient.

KW - Cancer survivorship

KW - Reproductive health

UR - http://www.scopus.com/inward/record.url?scp=85050700693&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85050700693&partnerID=8YFLogxK

U2 - 10.1007/s00520-018-4360-5

DO - 10.1007/s00520-018-4360-5

M3 - Article

C2 - 30051202

AN - SCOPUS:85050700693

JO - Supportive Care in Cancer

JF - Supportive Care in Cancer

SN - 0941-4355

ER -